Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Gene expression profiling of triple-negative breast tumors with different expression of secreted protein acidic and cysteine rich (SPARC)

Full text
de Alcantara Filho, Paulo R. [1, 2, 3] ; Mangone, Flavia R. [2] ; Pavanelli, Ana C. [2] ; de Bessa Garcia, Simone A. [1, 2] ; Nonogaki, Suely [4] ; de Toledo Osorio, Cynthia A. B. [4] ; de Andrade, Victor P. [4] ; Nagai, Maria A. [1, 2]
Total Authors: 8
[1] Univ Sao Paulo, Fac Med, Dept Radiol & Oncol, Discipline Oncol, BR-01246903 Sao Paulo - Brazil
[2] Canc Inst State Sao Paulo ICESP, Ctr Translat Res Oncol, Lab Mol Genet, BR-01246000 Sao Paulo - Brazil
[3] AC Camargo Canc Ctr, Dept Breast Surg, BR-01509020 Sao Paulo - Brazil
[4] AC Camargo Canc Ctr, Dept Pathol, BR-01509020 Sao Paulo - Brazil
Total Affiliations: 4
Document type: Journal article
Source: BREAST CANCER MANAGEMENT; v. 7, n. 2 MAY 2018.
Web of Science Citations: 0

Aim: To determine the expression signature of triple-negative breast cancer (TNBC) with differences of secreted protein acidic and rich in cysteine expression and clinical behavior. Patients, materials \& methods: cDNA microarray analysis was performed to determine the expression profiling of TNBC, characterized regarding secreted protein acidic and rich in cysteine expression status. Immunohistochemistry analysis on tissue microarrays containing an independent cohort of TNBC was performed for validation. Results: Negative staining of SOHLH2 and positive staining of DNAJC12 and LIM1 was correlated with a poor outcome of the patients. Conclusion: Our findings provide new information on transcriptome changes associated with the clinical behavior of TNBC that may serve as a potential tool for the identification and characterization of new candidate biomarkers. (AU)

FAPESP's process: 13/07035-4 - Evaluation of the functional role of intracellular and extracellular expression of PAR-4 (prostate apoptosis response-4) in the tumorigenic process of the breast: implications for chemosensitivity and potential antitumor
Grantee:Maria Aparecida Nagai
Support type: Regular Research Grants